|
1
|
Flanigan MJ: Role of sodium in
hemodialysis. Kidney Int Suppl. 58 (Suppl 76):S72–S78.
2000.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Suhail M: Na+,
K+-ATPase: Ubiquitous multifunctional transmembrane
protein and its relevance to various pathophysiological conditions.
J Cli Med Res. 2:1–17. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Adrogue HJ and Madias NE: Hypernatremia. N
Engl J Med. 342:1493–1499. 2000.PubMed/NCBI View Article : Google Scholar
|
|
4
|
De Luca L, Klein L, Udelson JE, Orlandi C,
Sardella G, Fedele F and Gheorghiade M: Hyponatremia in patients
with heart failure. Am J Cardiol. 96:19–23. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Papacocea MT, Badarau IA, Radoi M and
Papacocea IR: The predictive role of biochemical plasma factors in
patients with severe traumatic brain injuries. Rev Chim Buchar.
70:1754–1757. 2019.
|
|
6
|
Balan DG, Stroescu AEB, Tanasescu MD,
Diaconescu A, Raducu L, Mihai A, Tanase M, Stanescu II and Ionescu
D: Nutritional intervention in patients with diabetic renal
diseasee. A brief presentation. Rev Chim Buchar. 69:3178–3182.
2018.
|
|
7
|
Maduell F and Navarro V: Dietary salt
intake and blood pressure control in haemodialysis patients.
Nephrol Dial Transplant. 15(2063)2000.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lambie SH, Taal MW, Fluck RJ and McIntyre
CW: Online conductivity monitoring: Validation and usefulness in a
clinical trial of reduced dialysate conductivity. ASAIO J.
51:70–76. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fouque D, Vexnnegoor M, ter Wee P, Wanner
C, Basci A, Canaud B, Haage P, Konner K, Kooman J, Martin-Malo A,
et al: EBPG guideline on nutrition. Nephrol Dial Transplant. 22
(Suppl 2):ii45–ii87. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kutlugün AA, Arici M, Yıldırım T, Turgut
D, Yılmaz R, Altındal M, Altun B, Erdem Y, Yasavul U and Turgan C:
Daily sodium intake in chronic kidney disease patients during
nephrology clinic follow-up: An observational study with 24-hour
urine sodium measurement. Nephron Clin Pract. 118:C361–C366.
2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Santos SFF and Peixoto AJ: Sodium balance
in maintenance hemodialysis. Semin Dial. 23:549–555.
2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Silberberg JS, Barre PE, Prichard SS and
Sniderman AD: Impact of left ventricular hypertrophy on survival in
end-stage renal disease. Kidney Int. 36:286–290. 1989.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Balcangiu-Stroescu AE, Tanasescu MD,
Diaconescu AC, Raducu L, Balan DG, Mihai A, Tanase M, Stanescu II
and Ionescu D: Diabetic nephropathy: A concise assessment of the
causes, risk factors and implications in diabetic patients. Rev
Chim Buchar. 69:3118–3121. 2018.
|
|
14
|
Epingeac ME, Gaman MA, Diaconu C, Gad M
and Gaman AM: The evaluation of oxidative stress in obesity. Rev
Chim Buchar. 70:2241–2244. 2019.
|
|
15
|
Diaconu C: Treatment of diabetes in
patients with heart failure. In: The 3rd International conference
on interdisciplinary management of diabetes mellitus and its
complications - diabetes mellitus in internal medicine, INTERDIAB
2017 Proceedings. Serafinceanu C, Negoita O and Elian V (eds.)
Niculescu, Bucharest pp170-177, 2017.
|
|
16
|
Savu O, Ionescu-Tirgoviste C, Atanasiu V,
Gaman L, Papacocea R and Stoian I: Increase in total antioxidant
capacity of plasma despite high levels of oxidative stress in
uncomplicated type 2 diabetes mellitus. J Int Med Res. 40:709–716.
2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Totan A, Balcangiu-Stroescu AE, Melescanu
Imre M, Miricescu D, Balan DG, Stanescu II, Ionescu D, Timofte D,
Tanasescu MD and Greabu M: XOR-possible correlations with oxidative
stress and inflammation markers in the context of diabetic kidney
disease. Rev Chim Buchar. 70:1396–1398. 2019.
|
|
18
|
Timofte D, Mandita A, Balcangiu-Stroescu
AE, Balan DG, Raducu L, Tanasescu MD, Diaconescu AC, Dorin D,
Cosconel CI, Stoicescu SM, et al: Hyperuricemia and cardiovascular
diseases - clinical and paraclinical correlations. Rev Chim Buchar.
70:1045–1046. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gaman MA, Dobrica EC, Pascu EG, Cozma MA,
Epingeac ME, Gaman AM, Pantea Stoian A, Bratu OG and Diaconu CC:
Cardiometabolic risk factors for atrial fibrillation in type 2
diabetes mellitus: Focus on hypertension, metabolic syndrome and
obesity. J Mind Med Sci. 6:157–161. 2019.
|
|
20
|
Balcangiu-Stroescu AE, Tanasescu MD,
Diaconescu AC, Raducu L, Constantin AM, Balan DG, Ţarmure V and
Ionescu D: Cardiovascular comorbidities, inflammation and serum
albumin levels in a group of hemodialysis patients. Rev Chim
Buchar. 69:926–929. 2018.
|
|
21
|
Wright J and Hutchison A: Cardiovascular
disease in patients with chronic kidney disease. Vasc Health Risk
Manag. 5:713–722. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hemodialysis Adequacy 2006 Work Group.
Clinical practice guidelines for hemodialysis adequacy, update
2006. Hemodialysis adequacy 2006 work group. Am J Kidney Dis. 48
(Suppl 1):S2–S90. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Agarwal R: Hypertension and survival in
chronic hemodialysis patients - past lessons and future
opportunities. Kidney Int. 67:1–13. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lacson E Jr and Lazarus JM: The
association between blood pressure and mortality in ESRD - not
different from the general population? Semin Dial. 20:510–517.
2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Peixoto AJ and Santos SF: Blood pressure
management in hemodialysis: What have we learned? Curr Opin Nephrol
Hypertens. 19:561–566. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kalantar-Zadeh K, Regidor DL, Kovesdy CP,
Van Wyck D, Bunnapradist S, Horwich TB and Fonarow GC: Fluid
retention is associated with cardiovascular mortality in patients
undergoing long-term hemodialysis. Circulation. 119:671–679.
2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tomson CR: Advising dialysis patients to
restrict fluid intake without restricting sodium intake is not
based on evidence and is a waste of time. Nephrol Dial Transplant.
16:1538–1542. 2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
K/DOQI clinical practice guidelines for
cardiovascular disease in dialysis patients. Am J Kidney Dis.
45:1–153. 2005.PubMed/NCBI
|
|
29
|
Mandita A, Timofte D, Balcangiu-Stroescu
AE, Balan DG, Raducu L, Tanasescu MD, Diaconescu AC, Dorin D,
Cosconel CI, Stoicescu SM, et al: Treatment of high blood pressure
in patients with chronic renal disease. Rev Chim Buchar.
70:993–995. 2019.
|
|
30
|
Stefánsson BV, Brunelli SM, Cabrera C,
Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE and Stalhammar N-O:
Intradialytic hypotension and risk of cardiovascular disease. Clin
J Am Soc Nephrol. 9:2124–2132. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chou JA, Streja E, Nguyen DV, Rhee CM, Obi
Y, Inrig JK, Amin A, Kovesdy CP, Sim JJ and Kalantar-Zadeh K:
Intradialytic hypotension, blood pressure changes and mortality
risk in incident hemodialysis patients. Nephrol Dial Transplant.
33:149–159. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Emili S, Black NA, Paul RV, Rexing CJ and
Ullian ME: A protocol-based treatment for intradialytic hypotension
in hospitalized hemodialysis patients. Am J Kidney Dis.
33:1107–1114. 1999.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Daugirdas JT: Pathophysiology of dialysis
hypotension: An update. Am J Kidney Dis. 38 (4 Suppl 4):S11–S17.
2001.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Perazella MA: Pharmacologic options
available to treat symptomatic intradialytic hypotension. Am J
Kidney Dis. 38 (4 Suppl 4):S26–S36. 2001.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Parker T III: Creating an open dialogue on
improving dialysis care. Nephrol News Issues.
27(14,16)2013.PubMed/NCBI
|
|
36
|
Rayner HC, Zepel L, Fuller DS, Morgenstern
H, Karaboyas A, Culleton BF, Mapes DL, Lopes AA, Gillespie BW,
Hasegawa T, et al: Recovery time, quality of life, and mortality in
hemodialysis patients: The dialysis outcomes and practice patterns
study (DOPPS). Am J Kidney Dis. 64:86–94. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kuipers J, Verboom LM, Ipema KJR, Paans W,
Krijnen WP, Gaillard CAJM, Westerhuis R and Franssen CFM: The
prevalence of intradialytic hypotension in patients on conventional
hemodialysis: A systematic review with meta-analysis. Am J Nephrol.
49:497–506. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Flythe JE, Curhan GC and Brunelli SM:
Disentangling the ultrafiltration rate - mortality association: The
respective roles of session length and weight gain. Clin J Am Soc
Nephrol. 8:1151–1161. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lee MJ, Doh FM, Kim CH, Koo HM, Oh HJ,
Park JT, Han SH, Yoo TH, Kim YL, Kim YS, et al: Interdialytic
weight gain and cardiovascular outcome in incident hemodialysis
patients. Am J Nephrol. 39:427–435. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Palmer BF: Individualizing the dialysate
in the hemodialysis patient. Semin Dial. 14:41–49. 2001.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Choi HY and Ha SK: Potassium balance in
maintenance hemodialysis. Electrolyte Blood Press. 11:9–16.
2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Pun PH, Lehrich RW, Honeycutt EF, Herzog
CA and Middleton JP: Modifiable risk factors associated with sudden
cardiac arrest within hemodialysis clinics. Kidney Int. 79:218–227.
2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Kovesdy CP, Regidor DL, Mehrotra R, Jing
J, McAllister CJ, Greenland S, Kopple JD and Kalantar-Zadeh K:
Serum and dialysate potassium concentrations and survival in
de-modialysis patients. Clin J Am Soc Nephrol. 2:999–1007.
2007.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Karaboyas A, Zee J, Brunelli SM, Usvyat
LA, Weiner DE, Maddux FW, Nissenson AR, Jadoul M, Locatelli F,
Winkelmayer WC, et al: Dialysate potassium, serum potassium,
mortality, and arrhythmia events in hemodialysis: Results From the
Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney
Dis. 69:266–277. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Stone M, Martyn L and Weaver C: Potassium
intake, bioavailability, hypertension, and glucose control.
Nutrients. 8(444)2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Putcha N and Allon M: Management of
hyperkalemia in dialysis patients. Semin Dial. 20:431–439.
2007.PubMed/NCBI View Article : Google Scholar
|
|
47
|
National Kidney Foundation: Potassium and
your CKD diet. urihttps://www.kidney.org/atoz/content/potassiumsimplehttps://www.kidney.org/atoz/content/potassium.
Accessed May 15, 2020.
|
|
48
|
Basti C and Hayslett J: The cellular
action of aldosterone in target epithelia. Kidney Int.
42(250)1992.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Young DB, Smith MJ Jr, Jackson TE and
Scott RE: Multiplicative interaction between angiotensin II and K
concentration in stimulation of aldosterone. Am J Physiol.
247:E328–E345. 1984.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Mount DB and Zandi-Nejad K: Hyperkalemia.
In: The Kidney. Brenner BM (ed.) PA: Saunders., Philadelphia,
pp1017-1025, 2004.
|
|
51
|
U.S. Renal Data System: Annual Data
Report: Reference Tables. urihttps://www.usrds.org/reference.aspxsimplehttps://www.usrds.org/reference.aspx.
Accessed May 15, 2020.
|
|
52
|
Lowrie EG and Lew NL: Death risk in
hemodialysis patients: The predictive value of commonly measured
variables and an evaluation of death rate differences between
facilities. Am J Kidney Dis. 15:458–482. 1990.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Iseki K, Uehara H, Nishime K, Tokuyama K,
Yoshihara K, Kinjo K, Shiohira Y and Fukiyama K: Impact of the
initial levels of laboratory variables on survival in chronic
dialysis patients. Am J Kidney Dis. 28:541–548. 1996.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Evans KJ and Greenberg A: Hyperkalemia: A
review. J Intensive Care Med. 20:272–290. 2005.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Martin RS, Panese S, Virginillo M, Gimenez
M, Litardo M, Arrizurieta E and Hayslett JP: Increased secretion of
potassium in the rectum of man with chronic renal failure. Am J
Kidney Dis. 8:105–110. 1986.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Sandle GI, Tapster S and Goodship TH:
Evidence for large intestinal control of potassium homeostasis in
uremic patients undergoing long-term dialysis. Clin Sci (Lond).
73:247–252. 1987.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Allon M, Takeshian A and Sanklin N: Effect
of insulin-plus glucose infusion with or without epinephrine on
fasting hyperkalemia. Kidney Int. 43:212–217. 1993.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Massry SG: Renal failure, parathyroid
hormone and extrarenal disposal of potassium. Miner Electrolyte
Metab. 16:77–81. 1990.PubMed/NCBI
|
|
59
|
Goldfarb S, Cox M, Singer I and Goldberg
M: Acute hyperkalemia induced by hyperglycemia: Hormonal
mechanisms. Ann Intern Med. 84:426–432. 1976.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Moreno M, Murphy C and Goldsmith C:
Increase in serum potassium resulting from the administration of
hypertonic mannitol and other solutions. J Lab Clin Med.
73:291–298. 1969.PubMed/NCBI
|
|
61
|
Gennari FJ: Disorders of potassium
homeostasis: Hypokalemia and hyperkalemia. Crit Care Clin.
18:273–288. 2002.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Ahmed J and Weisberg LS: Hyperkalemia in
dialysis patients. Semin Dial. 14:348–356. 2001.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Kim HJ: Pathogenesis and treatment of
dyskalemia in maintenance hemodialysis and CAPD. Electrolyte Blood
Press. 4:47–52. 2006.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Parham WA, Mehdirad AA, Biermann KM and
Freman CS: Hyperkalemia revisited. Tex Heart Inst J. 33:40–47.
2006.PubMed/NCBI
|
|
65
|
Szerlip HM, Weiss J and Singer I: Profound
hyperkalemia without electrocardiographic manifestations. Am J
Kidney Dis. 7:461–465. 1986.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Musso CG: Potassium metabolism in patients
with chronic kidney disease. Part II: Patients on dialysis (stage
5). Int Urol Nephrol. 36:469–472. 2004.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Pun PH and Middleton JP: Dialysate
potassium, dialysate magnesium, and hemodialysis risk. J Am Soc
Nephrol. 28:3441–3451. 2017.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Locatelli F, La Milia V, Violo L, Del
Vecchio L and Di Filippo S: Optimizing haemodialysate composition.
Clin Kidney J. 8:580–589. 2015.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Acker CG, Johnson JP, Palevsky PM and
Greenberg A: Hyperkalemia in hospitalized patients: Causes,
adequacy of treatment, and results of an attempt to improve
physician compliance with published therapy guidelines. Arch Intern
Med. 158:917–924. 1998.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Hoskote SS, Joshi SR and Ghosh AK:
Disorders of potassium homeostasis: Pathophysiology and management.
J Assoc Physicians India. 56:685–693. 2008.PubMed/NCBI
|
|
71
|
Hwang JC, Wang CT, Chen CA and Chen HC:
Hypokalemia is associated with increased mortality rate in chronic
hemodialysis patients. Blood Purif. 32:254–261. 2011.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Podrid PJ: Potassium and ventricular
arrhythmias. Am J Cardiol. 65:E33–E44, Discussion E52.
1990.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Zehnder C, Gutzwiller JP, Huber A,
Schindler C and Schneditz D: Low-potassium and glucose-free
dialysis maintains urea but enhances potassium removal. Nephrol
Dial Transplant. 1:78–84. 2001.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Weisberg LS and Rachoin JS: The safety of
low-potassium dialysis. Semin Dial. 23:556–560. 2010.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Drueke TB and Lacour B: Disorders of
calcium, phosphate, and magnesium metabolism. In: Comprehensive
Clinical Nephrology. Freehally J, Floege J and Johnson RJ (eds.)
Mosby-Elsevier, Philadelphia, pp123-140, 2007.
|
|
76
|
Toribara TY, Terepka AR and Dewey PA: The
ultrafiltrable calcium of human serum. I. Ultrafiltration methods
and normal values. J Clin Invest. 36:738–748. 1957.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Loken HF, Havel RJ, Gordan GS and
Whittington SL: Ultracentrifugal analysis of protein bound and free
calcium in human serum. J Biol Chem. 235:3654–3658. 1960.PubMed/NCBI
|
|
78
|
Institute of Medicine (US) Committee to
review dietary reference intakes for vitamin D and calcium. Ross
AC, Taylor CL, Yaktine AL and Del Valle HB: Dietary reference
intakes for calcium and vitamin D. Washington (DC): National
Academies Press (US); 2011. Overview of calcium. Available from:
urihttps://www.ncbi.nlm.nih.gov/books/NBK56060/simplehttps://www.ncbi.nlm.nih.gov/books/NBK56060/.
Accessed May 20, 2020.
|
|
79
|
Papacocea T, Buraga I, Papacocea R,
Badarau I, Buraga M, Ciornei C and Danil A: Antioxidant enzymes -
potential targets in intracerebral haemorrhage. Farmacia.
62(1118)2014.
|
|
80
|
Kidney disease: Improving Global Outcomes
(KDIGO) CKD-MBD update work group: KDIGO 2017 Clinical practice
guideline update for the diagnosis, evaluation, prevention, and
treatment of chronic kidney disease-mineral and bone disorder
(CKD-MBD). Kidney Int Suppl. 7:1–59. 2017.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Bailey RL, Dodd KW, Goldman JA, Gahche JJ,
Dwyer JT, Moshfegh AJ, Sempos CT and Picciano MF: Estimation of
total usual calcium and vitamin D intake in the United States. J
Nut. 140:817–22. 2010.PubMed/NCBI View Article : Google Scholar
|
|
82
|
National Kidney Foundation. K/DOQI
clinical practice guidelines for bone metabolism and disease in
chronic kidney disease. Am J Kidney Dis. 42 (4 Suppl 3):S1–S201.
2003.PubMed/NCBI
|
|
83
|
Hoenderop JG, Muller D, Suzuki M, van Os
CH and Bindels RJ: Epithelial calcium channel: Gate-keeper of
active calcium reabsorption. Curr Opin Nephrol Hypertens. 9:335–40.
2000.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Bronner F and Stein WD: Calcium
homeostasis - an old problem revisited. J Nutr. 125 (Suppl
7):S1987–S1995. 1995.PubMed/NCBI View Article : Google Scholar
|
|
85
|
van der Sande FM, ter Meulen KJA, Kotanko
P and Kooman JP: Dialysate calcium levels: Do they matter? Blood
Purif. 47:230–235. 2019.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Saha H, Harmoinen A, Pietilä K, Mörsky P
and Pasternack A: Measurement of serum ionized versus total levels
of magnesium and calcium in hemodialysis patients. Clin Nephrol.
46:326–331. 1996.PubMed/NCBI
|
|
87
|
Block GA, Klassen PS, Lazarus JM, Ofsthun
N, Lowrie EG and Chertow GM: Mineral metabolism, mortality, and
morbidity in maintenance hemodialysis. J Am Soc Nephrol.
15:2208–2218. 2004.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Kalantar-Zadeh K, Kuwae N, Regidor DL,
Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff
MJ, Salusky IB and Kopple JD: Survival predictability of time -
varying indicators of bone disease in maintenance hemodialysis
patients. Kidney Int. 70:771–780. 2006.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Savoiu Balint G, Iovanescu G, Stanca HT,
Popoiu CM, Boia E, Popovici AR and Bolintineanu SL: The protective
effect of HDL-cholesterol in patients with essential hypertension.
Rev Chim Buchar. 68:949–952. 2017.
|
|
90
|
Timofte D, Ionescu D, Medrihan L, Mandita
A, Rasina A and Damian L: Vascular calcification and bone disease
in hemodialysis patients assessment, association and risk factors.
Nephrology Dialysis Transplantation. 22:325–326. 2007.
|
|
91
|
Timofte D, Dragos D, Balcangiu-Stroescu
A-E, Tanasescu M-D, Balan DG, Raducu L, Tulin A, Stiru O and
Ionescu D: Abdominal aortic calcification in predialysis patients:
Contribution of traditional and uremia-related risk factors. Exp
Ther Med. 20:97–102. 2020.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Stevens LA, Li S, Wang C, Huang C, Becker
BN, Bomback AS, Brown WW, Burrows NR, Jurkovitz CT, McFarlane SI,
et al: Prevalence of CKD and comorbid illness in elderly patients
in the United States: Results from the Kidney Early Evaluation
Program (KEEP). Am J Kidney Dis. 55 (3 Suppl 2):S23–S33.
2010.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Miller JE, Kovesdy CP, Norris KC, Mehrotra
R, Nissenson AR, Kopple JD and Kalantar-Zadeh K: Association of
cumulatively low or high serum calcium levels with mortality in
long-term hemodialysis patients. Am J Nephrol. 32:403–413.
2010.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Duval M, Bach K, Masson D, Guimard C, Le
Conte P and Trewick D: Is severe hypocalcemia immediately
life-threatening? Endocr Connect. 7:1067–1074. 2018.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Jimenez ZN, Silva BC, Reis LD, Castro MC,
Ramos CD, Costa-Hong V, Bortolotto LA, Consolim-Colombo F,
Dominguez WV, Oliveira IB, et al: High dialysate calcium
concentration may cause more sympathetic stimulus during
hemodialysis. Kidney Blood Press Res. 41:978–985. 2016.PubMed/NCBI View Article : Google Scholar
|
|
96
|
McGill RL and Weiner DE: Dialysate
composition for hemodialysis: Changes and changing risk. Semin
Dial. 30:112–120. 2017.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Pun PH, Horton JR and Middleton JP:
Dialysate calcium concentration and the risk of sudden cardiac
arrest in hemodialysis patients. Clin J Am Soc Nephrol. 8:797–803.
2013.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Genovesi S, Rossi E, Nava M, Riva H, De
Franceschi S, Fabbrini P, Viganò MR, Pieruzzi F, Stella A,
Valsecchi MG and Stramba-Badiale M: A case series of chronic
hemodialysis patients: Mortality, sudden death, and QT interval.
Europace. 15:1025–1033. 2013.PubMed/NCBI View Article : Google Scholar
|
